{"id":"NCT03681093","sponsor":"Novartis Pharmaceuticals","briefTitle":"Study of Efficacy of Fevipiprant in Patients With Nasal Polyposis and Asthma","officialTitle":"A Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of Fevipiprant Once Daily Plus Standard-of-care (SoC) for Assessment of the Efficacy in Reduction of Nasal Polyp Size in Patients With Nasal Polyposis and Concomitant Asthma.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-03-26","primaryCompletion":"2020-05-29","completion":"2020-06-10","firstPosted":"2018-09-21","resultsPosted":"2021-01-05","lastUpdate":"2021-10-11"},"enrollment":98,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Nasal Polyps"],"interventions":[{"type":"DRUG","name":"Fevipiprant 150 mg","otherNames":[]},{"type":"DRUG","name":"Fevipiprant 450 mg","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Fevipiprant 150 mg","type":"EXPERIMENTAL"},{"label":"Fevipiprant 450 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"A Phase 3b Proof-of-Concept study to evaluate the ability of fevipiprant 150 mg and 450 mg, compared with placebo, as add-on to nasal spray standard-of-care (SoC), in reducing endoscopic nasal polyp score in adult (â‰¥ 18 years) patients with nasal polyposis and concomitant asthma.","primaryOutcome":{"measure":"Change From Baseline in Nasal Polyp Score at Week 16","timeFrame":"Baseline, Week 16","effectByArm":[{"arm":"Fevipiprant 150 mg","deltaMin":0.2,"sd":0.224},{"arm":"Fevipiprant 450 mg","deltaMin":-0.1,"sd":0.216},{"arm":"Placebo","deltaMin":0.14,"sd":0.233}],"pValues":[{"comp":"OG000 vs OG002","p":"0.979"},{"comp":"OG001 vs OG002","p":"0.656"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":7},"locations":{"siteCount":25,"countries":["United States","Argentina","Belgium","Canada","Czechia","Germany","Italy","Netherlands","Poland"]},"refs":{"pmids":[],"seeAlso":["https://www.novctrd.com/ctrdweb/patientsummary/patientsummaries?patientSummaryId=732"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":32},"commonTop":["Sinusitis","Asthma","Influenza","Nasopharyngitis","Oral herpes"]}}